Design
Review
Authors
Loading...
Should not yet change clinical management of autonomic dysfunction in heart disease; leaves open targeted cyclic nucleotide therapies for future trials.
Key points are not available for this paper at this time.
Li et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: